Project Grant R01HL174735
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $743,388 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The grant aims to establish the role of cortisol rhythms in the development of insulin resistance from sleep restriction and circadian misalignment, which can lead to type 2 diabetes. The researchers will conduct two randomized placebo-controlled trials in 48 adults aged...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $691,124 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Michigan to conduct research on the relationship between circadian disruption and cardiometabolic risk during the transition from adolescence to young adulthood. The 5-year project, awarded on May 1, 2025, will leverage objective sleep/wake assessments and cardiometabolic biomarkers collected from over 500...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $172,085 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the University of Arizona to examine the feasibility and preliminary efficacy of two evening light mitigation strategies to advance the timing of sleep and the circadian clock in children aged 5-6.9 years with parent-reported sleep onset difficulties. The 5-year project, which began on August 1, 2025, will randomly assign children to one of...
- This federal Project Grant award of $539,342 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research on the role of circadian mechanisms in governing cardiac growth and the impact of comorbidities like obesity and diabetes on cardiovascular disease. The research, conducted by the University of Alabama at Birmingham, aims to elucidate the precise mechanisms by which the cardiomyocyte circadian clock promotes...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $762,550 to Seattle Children's Hospital to conduct a longitudinal study on the relationship between sleep deficiency and menstrual pain in adolescent females. The study aims to: (1) compare sleep patterns and psychological mechanisms across different menstrual cycle phases; (2)...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $450,000 in funding to Old Dominion University to investigate the relationship between disturbed sleep and the development of vulnerable atherosclerotic plaques. The primary objectives are to: 1) examine the role of NADPH-dependent oxidative stress in accelerating the formation of vulnerable atherosclerotic plaques in...
- This $730,993 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research on the mechanistic contribution of internal circadian misalignment to the cardiometabolic risk of sleep loss. The University of Utah is the awardee and plans to investigate how preventing light exposure and food intake during the circadian biological night can mitigate the adverse cardiometabolic effects of insufficient sleep. The research aims...
- The U.S. National Institutes of Health (NIH) awarded a $1,282,030 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to Yale University to conduct a pilot randomized trial titled "Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)." The project aims to test the feasibility and preliminary efficacy of a personalized intervention to address the social and clinical...
- This federal Project Grant award of $809,312, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to characterize circadian function and identify circadian dysfunction among children with Attention-Deficit/Hyperactivity Disorder (ADHD). The primary objectives are to: 1) Assess individual differences in circadian function and sleep profiles using laboratory-based dim light melatonin onset (DLMO) assessment and wearable...
- This Project Grant award of $160,092 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will support a longitudinal study to characterize sleep health, sleep disorders, and cognitive functioning among heart transplant recipients. The study will enroll 30 adult heart transplant recipients and collect repeated measurements at 6, 9, and 12 months post-transplant. Key objectives are to: (1) describe sleep health characteristics, sleep disorders, and...
MECHANISMS UNDERLYING THE RELATIONSHIP BETWEEN SLEEP HEALTH AND CIRCADIAN TIMING WITH CARDIOMETABOLIC RISK IN ADOLESCENTS WITH TYPE 1 DIABETES - PROJECT SUMMARY OUR RESEARCH HAS SHOWN A LINK BETWEEN POOR SLEEP HEALTH AND LATE CIRCADIAN TIMING WITH CARDIOMETABOLIC DYSFUNCTION IN ADOLESCENTS WITH TYPE 1 DIABETES (T1D). FURTHER, SLEEP HEALTH AND CIRCADIAN TIMING OF ADOLESCENTS WITH T1D PARTICIPATING IN OUR RESEARCH WAS MARKEDLY POOR COMPARED TO AGE-BASED RECOMMENDATIONS. CARDIOVASCULAR DISEASE (CVD) IS THE LEADING CAUSE OF MORBIDITY AND MORTALITY IN T1D, WHICH BEGINS AS EARLY AS ADOLESCENCE, AND CURRENT THERAPIES ARE LIMITED. THUS, IT IS IMPERATIVE TO IDENTIFY COUNTERMEASURES, SUCH AS SLEEP HEALTH AND CIRCADIAN TIMING, TO IMPROVE CARDIOMETABOLIC HEALTH IN ADOLESCENTS WITH T1D. OUR CENTRAL HYPOTHESIS IS THAT THAT CARDIOMETABOLIC DYSFUNCTION ASSOCIATED WITH T1D CAN BE REDUCED BY IMPROVING SLEEP HEALTH AND CIRCADIAN TIMING. WE HAVE SUCCESSFULLY INCREASED SLEEP DURATION AND ADVANCED CIRCADIAN TIMING WITH A COMBINED BEHAVIORAL AND PHYSIOLOGICAL INTERVENTION IN ADOLESCENTS WITHOUT T1D. SIMULTANEOUSLY INTERVENING ON SLEEP HEALTH AND CIRCADIAN TIMING MAY REVERSE CARDIOMETABOLIC DYSFUNCTION BUT A GAP EXISTS WITH NO RESEARCH IN ADOLESCENTS WITH T1D. FURTHER, NO RESEARCH TO DATE HAS EXAMINED THE PHYSIOLOGICAL MECHANISMS UNDERLYING THE RELATIONSHIP BETWEEN SLEEP HEALTH AND CIRCADIAN TIMING AND CARDIOMETABOLIC DYSFUNCTION IN ADOLESCENTS WITH T1D. WE THEREFORE PROPOSE TO UTILIZE A COMBINED SLEEP HEALTH AND CIRCADIAN TIMING INTERVENTION AS A MECHANISTIC PROBE TO UNDERSTAND RELATIONSHIPS WITH CARDIOMETABOLIC HEALTH IN ADOLESCENTS WITH T1D. UTILIZING A RANDOMIZED CLINICAL TRIAL DESIGN AND A COMBINED FREE-LIVING AND IN-LABORATORY PARADIGM, WE WILL COMPARE THE EFFECT OF 1 MONTH OF OPTIMALLY-TIMED, LOW-DOSE PM MELATONIN AND AM BRIGHT LIGHT EXPOSURE PLUS INCREASED TIME IN BED TO AN ATTENTION- MATCHED CONTROL CONDITION IN ADOLESCENTS WITH T1D. WE WILL EVALUATE CHANGES IN INSULIN RESISTANCE, GLYCEMIC CONTROL, AND VASCULAR FUNCTIONING USING RIGOROUS ASSESSMENT METHODS, AND DETERMINE PHYSIOLOGICAL MECHANISMS. WE HYPOTHESIZE THAT INSULIN SENSITIVITY, GLYCEMIC CONTROL, AND VASCULAR FUNCTION WILL IMPROVE WITH A COMBINED SLEEP AND CIRCADIAN INTERVENTION, AND THAT INFLAMMATION, CORTISOL, AND LEPTIN WILL ACT AS MEDIATORS. THIS PROPOSAL WILL PROVIDE AN UNDERSTANDING OF MECHANISMS UNDERLYING THE RELATIONSHIP BETWEEN SLEEP HEALTH AND CIRCADIAN TIMING AND CARDIOMETABOLIC DYSFUNCTION IN ADOLESCENTS WITH T1D WHICH IS URGENTLY NEEDED AS A FIRST STEP TOWARDS DEVELOPING NEW THERAPIES TO MITIGATE CVD IN T1D.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $524.1k | 8/14/25 | ||
| Not listed | $0 | 8/6/25 | ||
| Not listed | $524.4k | 8/23/24 |